香港联交所最新数据显示，7月7日，Lu Chris Xiangyang增持来凯医药-B（HK2105）(02105)1.6846万股，每股作价7.1279港元，总金额约为12万港元。增持后最新持股数目约为5510.28万股，最新持股比例为12.26%。
补充资料：Shares held by Dr.Lu includes(i)27,592,316Shares held beneficially under his name,(ii)20,000,000Shares held by Ealex LLC of which Dr.Lu is the settlor,(iii)Share Options granted to Dr.Lu to subscribe for2,635,520Shares pursuant to the Pre-IPO Share Option Scheme,and(iv)4,875,000Shares underlying the RSUs granted under the2024Share Award Scheme.
